American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

Cost of sharing assistance program threatened by administration actions

Michael Pineda | Aug 25, 2020
Cost of sharing assistance has proved beneficial in helping chronically ill patients save money on much-needed medication.

The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »

PhRMA exec optimistic on COVID-19 vaccine

David Beasley | Aug 25, 2020
A system that allows for collaboration is the key to a successful COVID-19 vaccine, a PhRMA manufacturers executive said.

The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »

KARMANOS CANCER INSTITUTE: Karmanos Specialty Pharmacy (KSP) receives full, three-year accreditation from the Utilization Review Accreditation Commission (URAC)

American Pharmacy News Reports | Aug 23, 2020

Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. Read More »

TOLMAR: Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients with Central Precocious Puberty

American Pharmacy News Reports | Aug 22, 2020
FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty 45mg every 6 mon

Company increases U.S. manufacturing capacity of drug to ensure uninterrupted supply amid industry shortage Read More »

AHA releases best practices for cardiovascular disease

American Pharmacy News Reports | Aug 17, 2020
AHA outlines the best practices for genetic testing cardiovascular diseases.

The best practices for genetic testing for the management of cardiovascular diseases that are inherited have been outlined by the American Heart Association (AHA). Read More »

Health care organizations call for Congress to recognize pharmacists as providers of billable services

Benjamin Kibbey | Aug 17, 2020
A recent letter sent to Congressional leaders and signed by a coalition of 24 health care organizations calls on Congress to enable pharmacists to help alleviate the strain created by the COVID-19 pandemic.

A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »

MEDLY PHARMACY: Expands Digital Pharmacy Services Into Baltimore

American Pharmacy News Reports | Aug 15, 2020

Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market Read More »

APHA: Transparency, Safety and Availability Must Be Core Principles for Strengthening America's Drug Supply Chain

American Pharmacy News Reports | Aug 15, 2020

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Read More »

PHARMACY QUALITY SOLUTIONS: Announces Appointment of John Michael O’Brien to Board of Directors

American Pharmacy News Reports | Aug 9, 2020

PQS adds former Senior Advisor to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services to its Board of Directors Read More »

HUMANA: Ranks #1 for Customer Satisfaction for Mail Order in J.D. Power Pharmacy Study for Third Year in a Row

American Pharmacy News Reports | Aug 9, 2020

Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. Read More »

John Hopkins study seeks solution for cardiovascular complications of people living with HIV

American Pharmacy News Reports | Aug 7, 2020
A John Hopkins Medicine pilot study recently indicated the potential for a protein inhibitor to mitigate cardiovascular complications for people living with HIV, though researchers said more studies are needed.

A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »

AEI expert calls for coordinated world effort to distribute COVID-19 vaccine

John Sammon | Aug 6, 2020
An AEI health analyst calls for a world effort to distribute a COVID-19 vaccine to everyone.

James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »

Biopharmaceutical industry reports over 400 medicines, vaccines in development

American Pharmacy News Reports | Jul 31, 2020
More vaccines and medicines are needed to combat infectious diseases that are becoming more resistant to current medicines.

A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »

AGENUS: Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals

American Pharmacy News Reports | Jul 31, 2020

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, announced the closing of a $20 million equity investment, at $4.03 per share, by Betta Pharmaceuticals (SZ300558) bringing the total received to $35M. Read More »

LANNETT: To Launch Levorphanol Tablets

American Pharmacy News Reports | Jul 30, 2020

Signs Exclusive U.S. Distribution Agreement with Novitium Pharma Read More »

MHA: New Long-Term Care Pharmacy Study Highlights Unrecognized Outcomes and Cost Related to Patient Rx Interventions

American Pharmacy News Reports | Jul 26, 2020

MHA Study Reveals Member Medication Adherence Rates for Long-Term Care Pharmacies Serving Skilled Nursing and Assisted Living Patients Read More »

Johns Hopkins study shows no drug use relapse from behavioral therapy for PTSD

American Pharmacy News Reports | Jul 24, 2020
Research shows that cognitive behavioral therapy for PTSD does not cause drug use relapses.

Johns Hopkins researchers find that standard PTSD treatment does not cause drug use relapse. Read More »

Pharmaceutical companies want intellectual property protections to be key focus

Kyla Asbury | Jul 17, 2020
Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research related to COVID-19.

Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research and development (R&D) related to COVID-19, according to PhRMA. Read More »

DELMAR PHARMACEUTICALS: To Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals

American Pharmacy News Reports | Jul 17, 2020

Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET Read More »

Pharmaceutical industry works to find COVID-19 vaccine

Kayla Elder | Jul 14, 2020
Pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus.

Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »

  • «
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • ...
  • 32
  • 33
  • »
Trending

Brianna Allen, Senior Director of Public Affairs at PhRMA

PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'

Molly Jenkins, Director of Public Affairs for PhRMA

PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’

Dan DeNeui, CEO of FarmaKeio

Iowa board files charges against FarmaKeio, citing FDA and California actions

Luke Gale, Revenue Cycle Editor, HealthLeaders Media

HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’

Lenora S. Newsome PD Chairperson

Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up